Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.gujaratinject.com | |
Market Cap | 3.59 Cr. | |
Enterprise Value(EV) | 4.60 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.13 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 57.84 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 33.61 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | -1.70 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | -4.30 | Calculated using Price: 7.32 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.49 Cr. | 4,899,000 Shares |
FaceValue | 10 | |
Company Profile | ||
Gujarat Inject (Kerala) (GKIL) was incorporated on January 7, 1991 and obtained certificate for commencement of business on February 14, 1991. The company has been jointly promoted by the Kerala State Industrial Development Corporation (KSIDC), a wholly owned subsidiary of Government of Kerala undertaking and Gujarat Inject (GIL) and its associates. The company has received SIA registration to manufacture intravenous solutions at puddussey east, kanjikode, in palghat district in Kerala. |
1 Day |
|
-4.94% |
1 Week |
|
-13.48% |
1 Month |
|
-36.79% |
3 Month |
|
+5.93% |
6 Month |
|
+22.20% |
1 Year |
|
|
2 Year |
|
|
5 Year |
|
|
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | ||||||||||
Return on Capital Employed (%) | ||||||||||
Return on Assets (%) | -1.68 | -1.84 | 1,373.74 | 6.93 | -102.49 | -30.20 | 1.57 | -664.44 | 5.37 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | -3 | -3 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Curr. Liab. | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Non Curr. Assets | 0 | 0 | |||||||||
Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 0 | 2 | 0 | 0 | 0 | ||||||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Total Income | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | |||
Total Expenditure | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | |||
PBIDT | 0 | 0 | 0 | 0 | 0 | ||||||
Interest | |||||||||||
Depreciation | |||||||||||
Taxation | 0 | ||||||||||
Exceptional Items | 2 | ||||||||||
PAT | 2 | 0 | 0 | 0 | 0 | 0 | |||||
Adjusted EPS | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | |||||||||
Cash Fr. Inv. | |||||||||||
Cash Fr. Finan. | 0 | ||||||||||
Net Change | 0 | ||||||||||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fri, 30 Dec 2022
Closure of Trading Window Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and Companys Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities this is to inform that the trading window for dealing in Equity Shares of the Company by the Insiders covered under Companys Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities will be closed from Sunday January 01 2023 till 48 hours after the declaration and publication of Financial Results for the quarter ended December 31 2022. The above closure has been intimated based on BSE Circular no. LIST /COMP/01/2019 20 dated April 2 2019 - Clarification regarding trading restriction period and the Securities and Exchange Board of India (Prohibition of Insider Trading) (Second Amendment) Regulations 2019. |
Thu, 10 Nov 2022
Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. On November 10 2022 In Terms Of Second ProvisoTo Regulation 30(6) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. In reference to captioned subject we hereby inform you that the Board of Directors of the Company intheir Board Meeting held on today i.e. on November 10 2022 at the Administrative Office of the Companywhich was commenced at 04:45 PM and concluded at 05:00 PM has apart from other businesses considered approved and taken on record the Unaudited Financial Result of the Company for the quarter ended onSeptember 30 2022 along with Limited Review Report. |
Thu, 10 Nov 2022
Submission Of Unaudited Financial Result Of The Company For The Quarter Ended On September30 2022 Along With Limited Review Report. In reference to captioned subject and pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations andDisclosure Requirements) Regulations 2015 we are hereby submitting the followings:1. Unaudited Financial Results for the quarter ended on September 30 2022;2. Limited Review Report. |
Wed, 25 Jan 2023 |
|
|
|
|
|